Temporal relations among amyloid β-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses

Journal of Molecular Neuroscience

Volumn 11, Issue 3, 1998, Pages 183-197

  Yatin, Servet M ^a   Aksenova, Marina ^a   Aksenov, Michael ^b   Markesbery, William R ^b   Aulick, Timothy ^a   Allan Butterfield, D ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyloid peptide; Creatine kinase; Free radical; Oxidative stress; Protein carbonyl

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HUMAN CELL; NERVE CELL CULTURE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CREATINE KINASE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; HIPPOCAMPUS; ISOENZYMES; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SOLUBILITY; SPIN TRAPPING; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 0032429784     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:11:3:183     Document Type: Article

References (89)

1. 2+-dependent late phase. J. Neurochem. 67, 2074-2078.
2. Aksenov M. Y., Aksenova M. V., Carney J. M., and Butterfield D. A. (1997) Oxidative modification of glutamine synthetase by amyloid β-peptide. Free Radical Res. 27, 267-281.
3. Aksenov M. Y., Aksenova M. V., Markesbery W. R., and Butterfield D. A. (1998) Amyloid β-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons: protein carbonyl formation, CK BB expression and the level of Cu, Zn and Mn SOD mRNA. J. Mol. Neurosci., 10, 181-192.
4. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M., Romano D. M., Hartshorn M. A., Tanzi R. E., and Bush A. I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12,817-12,826.
5. Banerjee A., Grosso M. A., Brown J. M., Rogers K. B., and Whitman G. J. R. (1991) Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am. J. Physiol. 261, H590-H597.
6. Barger S. W. and Mattson M. P. (1996) Participation of gene expression in the protection against amyloid β-peptide toxicity by the β-amyloid precursor protein. Ann. N Y Acad. Sci. 777, 303-309.
7. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
8. Bass D. W., Parce J. W., DeChatelet R., Szejda P., Seeds M. C., and Thomas M. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910-1917.
9. Beal M. (1995) Aging, energy and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
10. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
11. Behl C. and Sagara Y. (1997) Mechanism of amyloid β protein induced neuronal cell death: current concepts and future perspectives. J. Neural. Transm. Suppl. 49, 125-134.
12. Behl C., Davis J., Cole G. M., and Shubert D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
13. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
14. Bruce A. J., Malfroy B., and Baudry M. (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93, 2312-2316.
15. Burbaeva G. S., Aksenova M. V., and Makarenko I. G. (1992) Decreased level of creatine kinase BB in the frontal cortex of Alzheimer patients. Dementia 3, 91-94.
16. Bush A. I., Huang X., Atwood C. S., Cherny R. A., Moir R. D., Goldstein L. E., O'Malley C. M., Saunders A. J., Multhaup G., Beyreuther K., Masters C. L., and Tanzi R. E. (1998) Interactions with ionic zinc, copper and iron govern Aβ redox activity and accumulation in Alzheimer's disease. Neurobiol. Aging 19(Suppl. 40), 168.
17. Butterfield D. A. (1982) Spin labeling in disease. Biol. Mag. Reson. 4, 1-78.
18. Butterfield D. A. (1997) β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10, 495-506.
19. Butterfield D. A. and Stadtman E. R. (1997) Protein oxidation process in aging brain. Adv. Cell Aging Gerontol. 2, 161-191.
20. Butterfield D. A., Hensley K., Harris M., Mattson M., and Carney J. M. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
21. Butterfield D. A., Hensley K., Cole P., Subramaniam R., Aksenov M., Aksenova M., Bummer P. M., Haley B. E., and Carney J. M. (1997) Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J. Neurochem. 68, 2451-2457.
22. Butterfield D. A., Varadarajan S., LaFontaine M., Subramaniam R., Koppal T., Yatin S., Hensley K., Aksenova M., and Aksenov M. (1998) Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. Neurobiol. Aging 19(Suppl. 262), 1097.
23. 2+: an alternate mechanism for the cardiotoxicity of doxorubicin. Toxicol. Appl. Pharmacol. 107, 117-128.
24. Chauhan A., Chauhan V. P., Brockerhoff H., and Wisniewski H. M. (1991) Action of amyloid β-protein on protein kinase C activity. Life Sci. 49, 1555-1562.
25. Cheng B., Christakos S., and Mattson M. P. (1994) Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
26. Chromzynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
27. Davies C. A., Mann D. M. A., Sumpter P. Q., and Yates P. O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with AD. J. Neurol. Sci. 78, 151-164.
28. DeKosky S. T. and Scheff S. W. (1990) Synapse loss in frontal cortex biopsies in AD: correlation with cognitive severity. Ann. Neurol. 27, 457-464.
29. Davis J. B. (1996) Oxidative mechanisms in β-amyloid cytotoxicity. Neurodegeneration 5, 441-444.
30. Dyrks T., Hartmann T., Masters C., and Beyreuther K. (1992) Amyloidgenicity of βA4 and βA4-bearing amyloid precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18,210-18,217.
31. + channels. Science 264, 276-279.
32. Friedlich A. L. and Butcher L. L. (1993) Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiol. Aging 15, 443-455.
33. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., et al. (1995) Alzheimertype neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
34. Glenney J. R. (1986) Antibody probing on Western blots have been stained with India ink. Anal. Biochem. 156, 315-318.
35. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. (1991) Segregation of missense mutation in the amyloid precursor protein. Biochem. Biophys. Res. Commun. 155, 608-614.
36. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Exp. Neurol. 128, 175-182.
37. Green L. M., Reade J. L., and Ware C. F. (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines J. Immunol. Methods 70, 257-268.
38. Gridley K. E., Green P. S., and Simpkins J. W. (1997) Low concentrations of estradiol reduce Aβ(25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma. Brain Res. 778, 158-165.
39. Guo Q., Robinson N., and Mattson M. P. (1998) Secreted-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NFkB and stabilization of calcium homeostasis. J. Biol. Chem. 273, 12,341-12,351.
40. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
41. Harman D. (1993) Free radical theory of aging: a hypothesis on pathogenesis of senile dementia of the Alzheimer's type. Age 16, 23-30.
42. Harris M., Hensley K., Butterfield D. A., Leedle R. A., and Carney J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer's β amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131, 193-202.
43. Hensley K., Carney J. M., Mattson M. P., Aksenova M. V., Harris M. E., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
44. Hensley K., Aksenova M., Carney J. M., and Butterfield D. A. (1995a) Amyloid β-peptide spin trapping I: enzyme toxicity is related to free radical spin trap reactivity. Neuroreport 6, 489-493.
45. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenova M., Aksenov M., Gabbita P., Carney J., Markesberry W., and Butterfield D. A. (1995b) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
46. Kinouchi H. Epstein C. J., Mizui T., Carlson E., Chen S. F., and Chan P. H. (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. USA 88, 11,158-11,162.
47. Koppal T., Subramaniam R., Drake J., Prasad M. R., and Butterfield D. A. (1998) Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 786, 270-273.
48. Laemmli U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
49. LeBel C. P., Ischiropoulus H., and Bondy S. C. (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227-231.
50. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S., and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478.
51. Levine R. L., Williams J. A., Stadtman E. R., and Shacter E. (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346-357.
52. Lovell M. A., Ehmann W. D., Mattson M. P., and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
53. Mark R., Hensley K., Butterfield D. A., and Mattson M. P. (1995) Amyloid β-peptide impairs ion-motive ATPase activities; evidence for a role in loss of neuronal Ca-homeostasis and cell death. J. Neurosci. 15, 6239-6249.
54. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
55. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
56. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-amyloid peptide destabilizes calcium homeostasis and renders human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
57. 2+ homeostasis Alzheimer's disease. Trends Neurosci. 16, 409-414.
58. Mattson M. P., Mark R. J., Furukawa K., and Bruce A. J. (1997a) Disruption of brain cell ion homeostasis in Alzheimer's disease by oxyradicals, and signalling pathways that protect therefrom. Chem. Res. Toxicol. 10, 507-517.
59. Mattson M. P., Begley J. G., Mark R. J., and Furukawa K. (1997b) Aβ(25-35) induces rapid lysis of red blood cells: contrast with Aβ(1-42) and examination of underlying mechanisms. Brain Res. 771, 147-153.
60. May P. C., Gitter B. D., Waters D. C., Simmons L. K., Becker G. W., and Small J. S., Robinson P. M. (1992) β-amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13, 605-607.
61. McCord J. M. (1979) Superoxide, superoxide dismutase and oxygen toxicity, in Reviews in Biochemical Toxicology, vol. 1 (Hodgson E., Bend J. R., and Philpot R. M., eds.), Elsevier, Amsterdam, pp. 109-124.
62. McCord J. M. and Russell W. J. (1988) Inactivation of creatine phosphokinase by superoxide during reperfusion injury, in Oxygen Radicals in Biology and Medicine (Simic K. A., Word J. F., and Von Sonntag C., eds.), Plenum, New York, pp. 869-873.
63. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods 65, 55-63.
64. Murrell J., Farlow M., Ghetti B., and Benson M. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
65. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M., and Floyd R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87, 5144-5147.
66. Pearson R. C., Esiri M. M., Hiorns R. W., Wilcock G. K., and Powell T. P. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci USA 82, 4531-4534.
67. Perry G., Richey P. L., Siedlak S. L., Smith M. A., Mulvihill P., DeWitt D. A., Barnett J., Greenberg B. D., and Kalaria R. N. (1993) Immunocytochemical evidence that the β-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 143, 1586-1593.
68. Pettegrew J. M., Panchalingam K., Klunk W. E., McClure R. J., and Muenz L. R. (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol. Aging 15, 117-132.
69. Refolo L M., Wittenberg I. S., Friedrich V. L. Jr., and Robakis N. K. (1991) The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J. Neurosci. 11, 3888-3897.
70. Richardson J. S. (1994) Free radicals in the genesis of Alzheimer's disease. Ann. NY Acad. Sci. 695, 73-76.
71. Sagara Y., Tan S., Maher P., and Schubert D. (1998) Mechanisms of resistance to oxidative stress in Alzheimer's disease. Biofactors 8, 45-50.
72. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., and Kimura H. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92, 1989-1993.
73. Selkoe D. J. (1989) The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer's disease. Ann. Med. 21, 73-76.
74. Selkoe D. J. (1996) Amyloid β-protein and genetics of Alzheimer's disease. J. Biol. Chem. 271, 18,295-18,298.
75. Shearman M. S., Hawtin S. R., and Tailor V. J. (1995) The intracellular component of cellular [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl] tetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J. Neurochem. 68, 218-227.
76. Sims N. R., Finegan J. M., Blass J. P., Bowen D, M., and Neary D. (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436, 30-38.
77. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., and Floyd R. A. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10,540-10,543.
78. Smith C. D., Carney J. M., Tatsuno, T., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1994) Protein oxidation in aging brain. Ann. NY Acad. Sci. 663, 110-119.
79. Smith M. A., Hirai K., Hsiao K., Pappolla M. A., Harris P. L., Siedlak S. L., Tabaton M., and Perry G. (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 2212-2215.
80. Stadtman E. R. (1992) Protein oxidation and aging. Science 257, 1120-1124.
81. Subramaniam R., Koppal T., Yatin S., Jordan B., and Butterfield D. A. (1998) The free radical antioxidant vitamin E protects cortical synaptosomal membrane proteins from amyloid β-peptide (25-35) toxicity but not from hydroxynonenal toxicity: Relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23, 1403-1410.
82. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., and Endo N. (1996) Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271, 6839-6844.
83. 2+ channels: A possible involvement of free radicals. J. Neurochem. 68, 265-271.
84. Wallace M. A. (1994) Effects of Alzheimer's disease-related β amyloid protein fragments on enzyme metabolizing, phosphoinositides in brain. Biochim. Biophys. Acta 1227, 183-187.
85. Wisniewski K., Wisniewski H., and Wen G. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.
86. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M. (1996) RAGE and amyloid β-peptide neurotoxicity in Alzheimer's disease Nature 382, 685-691.
87. Yankner B. A., Duffy L. K., and Kirschnier D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by Tachykinin neuropeptides. Science 250, 279-282.
88. Yatin S., Aksenov M., and Butterfield D. A. (1999) The antioxidant vitamin E modulates amyloid β-peptide induced creatine kinase activity inhibition and increased protein oxidation: Implications for the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 24, 427-435.
89. 2 generation. J. Neurochem. 67, 1595-1606.